The Velcade Brand and generic had U.S. sales of approximately $1.2 billion MAT for the most recent twelve months ending in May 2022
Lacosamide Injection is used to treat partial-onset seizures.
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The company has 47 ANDA's pending approval with the U.S.FDA
It is indicated for the treatment of patients with acromegaly and Gastroenteropancreatic Neuroendocrine Tumours
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal
Nelarabine is in a class of medications called antimetabolites
Subscribe To Our Newsletter & Stay Updated
